Hepatocellular Carcinoma: Resection versus Transplantation

Seminars in Liver Disease

Volumn 33, Issue 3, 2013, Pages 282-292

  Earl, Trumanm ^a   Chapman, Williamc ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

hepatic resection; hepatocellular carcinoma; intention to treat; liver transplantation; salvage transplantation

Indexed keywords

ABLATION THERAPY; ARTICLE; CADAVER DONOR; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CHEMOEMBOLIZATION; CHRONIC LIVER DISEASE; CHRONIC LIVER FAILURE; COMORBIDITY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; END STAGE LIVER DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENTION TO TREAT ANALYSIS; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; LYMPH NODE METASTASIS; ORGAN DONOR; OVERALL SURVIVAL; PATIENT SELECTION; PORTAL HYPERTENSION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; RECURRENCE RISK; SALVAGE THERAPY; SURVIVAL RATE; TUMOR NECROSIS;

CARCINOMA, HEPATOCELLULAR; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM STAGING; PATIENT SELECTION; REOPERATION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WAITING LISTS;

EID: 84881647180     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0033-1351783     Document Type: Article

References (88)

1. Llovet J. M., Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol: 2003; 38 01 S136 S149
2. Llovet J. M., Brú C., Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis: 1999; 19 3 329 338
3. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med: 1996; 334 11 693 699
4. Tsoulfas G., Kawai T., Elias N., et al. Long-term experience with liver transplantation for hepatocellular carcinoma. J Gastroenterol: 2011; 46 2 249 256
5. Island E. R., Pomposelli J., Pomfret E. A., Gordon F. D., Lewis W. D., Jenkins R. L. Twenty-year experience with liver transplantation for hepatocellular carcinoma. Arch Surg: 2005; 140 4 353 358
6. Trevisani F., Cantarini M. C., Labate A. M., et al. Italian Liver Cancer (ITALICA) group Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival. Am J Gastroenterol: 2004; 99 8 1470 1476
7. Tong M. J., Blatt L. M., Kao V. W. Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol: 2001; 16 5 553 559
8. Zhang B. H., Yang B. H., Tang Z. Y. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol: 2004; 130 7 417 422
9. Yuen M. F., Cheng C. C., Lauder I. J., Lam S. K., Ooi C. G., Lai C. L. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology: 2000; 31 2 330 335
10. Sharma P., Balan V., Hernandez J. L., et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl: 2004; 10 1 36 41
11. Washburn K. Model for end stage liver disease and hepatocellular carcinoma: a moving target. Transplant Rev (Orlando): 2010; 24 1 11 17
12. Bruix J., Llovet J. M. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology: 2002; 35 3 519 524
13. Bismuth H., Chiche L., Adam R., Castaing D., Diamond T., Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg: 1993; 218 2 145 151
14. Llovet J. M., Fuster J., Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology: 1999; 30 6 1434 1440
15. Poon R. T., Fan S. T., Lo C. M., et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg: 2001; 234 1 63 70
16. Belghiti J., Regimbeau J. M., Durand F., et al. Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology: 2002; 49 43 41 46
17. Cha C. H., Ruo L., Fong Y., et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg: 2003; 238 3 315 321, discussion 321-323
18. Bilimoria M. M., Lauwers G. Y., Doherty D. A., et al. International Cooperative Study Group on Hepatocellular Carcinoma Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg: 2001; 136 5 528 535
19. Llovet J. M., Fuster J., Bruix J. Barcelona-Clínic Liver Cancer Group The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl: 2004; 10 2 01 S115 S120
20. Yao F. Y., Bass N. M., Nikolai B., et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl: 2002; 8 10 873 883
21. Yao F. Y., Ferrell L., Bass N. M., et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology: 2001; 33 6 1394 1403
22. Bharat A., Brown D. B., Crippin J. S., et al. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg: 2006; 203 4 411 420
23. Chapman W. C., Majella Doyle M. B., Stuart J. E., et al. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann Surg: 2008; 248 4 617 625
24. Bralet M. P., Régimbeau J. M., Pineau P., et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology: 2000; 32 2 200 204
25. Grando-Lemaire V., Guettier C., Chevret S., Beaugrand M., Trinchet J. C. Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. J Hepatol: 1999; 31 3 508 513
26. El-Serag H. B., Davila J. A. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology: 2004; 39 3 798 803
27. Poon R. T., Fan S. T., Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg: 2002; 194 5 592 602
28. Belghiti J., Kianmanesh R. Surgical treatment of hepatocellular carcinoma. HPB (Oxford): 2005; 7 1 42 49
29. Shimozawa N., Hanazaki K. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg: 2004; 198 3 356 365
30. Vauthey J. N., Klimstra D., Franceschi D., et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg: 1995; 169 1 28 34, discussion 34-35
31. Ercolani G., Grazi G. L., Ravaioli M., et al. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg: 2003; 237 4 536 543
32. Roayaie S., Obeidat K., Sposito C., et al. Resection of hepatocellular cancer
33. Poon R. T., Fan S. T., Lo C. M., Liu C. L., Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg: 1999; 229 2 216 222
34. Li Q., Wang J., Juzi J. T., et al. Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma. J Gastrointest Surg: 2008; 12 9 1540 1547
35. Ng I. O., Guan X. Y., Poon R. T., Fan S. T., Lee J. M. Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis. J Pathol: 2003; 199 3 345 353
36. Poon R. T., Fan S. T., Lo C. M., Liu C. L., Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg: 2002; 235 3 373 382
37. Imamura H., Matsuyama Y., Tanaka E., et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol: 2003; 38 2 200 207
38. Poon R. T., Fan S. T., O'Suilleabhain C. B., Wong J. Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy. J Am Coll Surg: 2002; 195 3 311 318
39. Iwatsuki S., Gordon R. D., Shaw B. W. Jr, Starzl T. E. Role of liver transplantation in cancer therapy. Ann Surg: 1985; 202 4 401 407
40. O'Grady J. G., Polson R. J., Rolles K., Calne R. Y., Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg: 1988; 207 4 373 379
41. Olthoff K. M., Millis J. M., Rosove M. H., Goldstein L. I., Ramming K. P., Busuttil R. W. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg: 1990; 125 10 1261 1266, discussion 1266-1268
42. Onaca N., Davis G. L., Jennings L. W., Goldstein R. M., Klintmalm G. B. Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl: 2009; 15 6 574 580
43. Shetty K., Timmins K., Brensinger C., et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl: 2004; 10 7 911 918
44. Llovet J. M., Bruix J., Fuster J., et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology: 1998; 27 6 1572 1577
45. Yoo H. Y., Patt C. H., Geschwind J. F., Thuluvath P. J. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol: 2003; 21 23 4329 4335
46. Freeman R. B. Jr, Edwards E. B. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl: 2000; 6 5 543 552
47. Organ Procurement and Transplantation Network Organ Procurement and Transplantation Network. Health Resources and Services Administration, HHS. Final rule. Fed Regist: 1999; 64 202 56650 56661
48. Wiesner R. H., McDiarmid S. V., Kamath P. S., et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl: 2001; 7 7 567 580
49. Wiesner R., Edwards E., Freeman R., et al. United Network for Organ Sharing Liver Disease Severity Score Committee Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology: 2003; 124 1 91 96
50. Olthoff K. M., Brown R. S. Jr, Delmonico F. L., et al. Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl: 2004; 10 10 02 A6 A22
51. Freeman R. B., Wiesner R. H., Edwards E., Harper A., Merion R., Wolfe R. United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee Results of the first year of the new liver allocation plan. Liver Transpl: 2004; 10 1 7 15
52. Wiesner R. H., Freeman R. B., Mulligan D. C. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology: 2004; 127 5 01 S261 S267
53. Sharma P., Harper A. M., Hernandez J. L., et al. Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation. Am J Transplant: 2006; 6 8 1957 1962
54. Duffy J. P., Vardanian A., Benjamin E., et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg: 2007; 246 3 502 509, discussion 509-511
55. Onaca N., Klintmalm G. B. Liver transplantation for hepatocellular carcinoma: the Baylor experience. J Hepatobiliary Pancreat Sci: 2010; 17 5 559 566
56. Sarasin F. P., Majno P. E., Llovet J. M., Bruix J., Mentha G., Hadengue A. Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective. Hepatology: 2001; 33 5 1073 1079
57. Pelletier S. J., Fu S., Thyagarajan V., et al. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl: 2009; 15 8 859 868
58. Maddala Y. K., Stadheim L., Andrews J. C., et al. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Liver Transpl: 2004; 10 3 449 455
59. Mazzaferro V., Battiston C., Perrone S., et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg: 2004; 240 5 900 909
60. Llovet J. M., Real M. I., Montaña X., et al. Barcelona Liver Cancer Group Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet: 2002; 359 9319 1734 1739
61. Llovet J. M., Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology: 2003; 37 2 429 442
62. Lo C. M., Ngan H., Tso W. K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology: 2002; 35 5 1164 1171
63. Yao F. Y., Kinkhabwala M., LaBerge J. M., et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant: 2005; 5 4 Pt 1 795 804
64. Roayaie S., Frischer J. S., Emre S. H., et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg: 2002; 235 4 533 539
65. Kneteman N. M., Oberholzer J., Al Saghier M., et al. Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Liver Transpl: 2004; 10 10 1301 1311
66. Onaca N., Davis G. L., Goldstein R. M., Jennings L. W., Klintmalm G. B. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl: 2007; 13 3 391 399
67. Majno P. E., Adam R., Bismuth H., et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg: 1997; 226 6 688 701, discussion 701-703
68. Yao F. Y., Kerlan R. K. Jr, Hirose R., et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology: 2008; 48 3 819 827
69. Fuks D., Dokmak S., Paradis V., Diouf M., Durand F., Belghiti J. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology: 2012; 55 1 132 140
70. Facciuto M. E., Rochon C., Pandey M., et al. Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria. HPB (Oxford): 2009; 11 5 398 404
71. Sogawa H., Shrager B., Jibara G., Tabrizian P., Roayaie S., Schwartz M. Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis. HPB (Oxford): 2013; 15 2 134 141
72. Margarit C., Escartín A., Castells L., Vargas V., Allende E., Bilbao I. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl: 2005; 11 10 1242 1251
73. Nathan H., Bridges J. F., Schulick R. D., et al. Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol: 2011; 29 6 619 625
74. Nathan H., Segev D. L., Bridges J. F., et al. Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma. Ann Surg Oncol: 2013; 20 2 448 456
75. Sapisochin G., Castells L., Dopazo C., et al. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Ann Surg Oncol: 2013; 20 4 1194 1202
76. Dhir M., Lyden E. R., Smith L. M., Are C. Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis. HPB (Oxford): 2012; 14 9 635 645
77. Lee K. K., Kim D. G., Moon I. S., Lee M. D., Park J. H. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol: 2010; 101 1 47 53
78. Baccarani U., Isola M., Adani G. L., et al. Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma. Transpl Int: 2008; 21 3 247 254
79. Bellavance E. C., Lumpkins K. M., Mentha G., et al. Surgical management of early-stage hepatocellular carcinoma: resection or transplantation? J Gastrointest Surg: 2008; 12 10 1699 1708
80. Del Gaudio M., Ercolani G., Ravaioli M., et al. Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. Am J Transplant: 2008; 8 6 1177 1185
81. Shah S. A., Cleary S. P., Tan J. C., et al. An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution. Ann Surg Oncol: 2007; 14 9 2608 2614
82. Poon R. T., Fan S. T., Lo C. M., Liu C. L., Wong J. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg: 2007; 245 1 51 58
83. Bigourdan J. M., Jaeck D., Meyer N., et al. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl: 2003; 9 5 513 520
84. Weimann A., Schlitt H. J., Oldhafer K. J., Hoberg S., Tusch G., Raab R. Is liver transplantation superior to resection in early stage hepatocellular carcinoma? Transplant Proc: 1999; 31 1-2 500 501
85. Adam R., Azoulay D. Is primary resection and salvage transplantation for hepatocellular carcinoma a reasonable strategy? Ann Surg: 2005; 241 4 671 672
86. Belghiti J., Cortes A., Abdalla E. K., et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg: 2003; 238 6 885 892, discussion 892-893
87. Adam R., Azoulay D., Castaing D., et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg: 2003; 238 4 508 518, discussion 518-519
88. Cucchetti A., Vitale A., Gaudio M. D., et al. Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transplant: 2010; 10 3 619 627